# Known Allergy Status

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-known-allergy-" style="width: 667.25pt; border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;" width="890"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Title

</td><td style="width: 551.7pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Known Allergy Status

</td></tr><tr style="mso-yfti-irow: 1; height: 40.15pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="154">Description

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 40.15pt;" valign="top" width="736">Percent of patient records with documented allergy status, including ‘no known drug allergies’.

A higher rate is better.

</td></tr><tr style="mso-yfti-irow: 2; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Community pharmacies are the last step prior to a patient receiving a medication and last chance to verify drug allergies.

</td></tr><tr style="mso-yfti-irow: 3; height: 173.2pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="154">Logic Model

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 173.2pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/DEpimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/DEpimage.png)

<span style="mso-no-proof: yes;">  
</span>

This measure ensures the pharmacy has the salient information (allergy history) to ensure patient specific dosing.

</td></tr><tr style="mso-yfti-irow: 4; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Level of Analysis

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Pharmacy (Patient)

</td></tr><tr style="mso-yfti-irow: 5; height: 9.5pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="154">Data Source

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 9.5pt;" valign="top" width="736">Pharmacy Data

</td></tr><tr style="mso-yfti-irow: 6; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">All individuals dispensed a prescription from the pharmacy during a measurement year

</td></tr><tr style="mso-yfti-irow: 7; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>1. Identify all prescriptions in a measurement year

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>2. Identify all unique patients from the prescriptions

<span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">3.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>3. Apply exclusions

</td></tr><tr style="mso-yfti-irow: 8; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Denominator Exclusions

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Any non-human patients (e.g., cats, dogs, clinics, office-use, etc)

</td></tr><tr style="mso-yfti-irow: 9; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Denominator Exclusion Rationale

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">Pharmacies may provide care to pets or other veterinarian needs, or for office-use. This patient profiles should be excluded from the measure calculation.

</td></tr><tr style="mso-yfti-irow: 10; height: 20.05pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="154">Numerator Statement

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 20.05pt;" valign="top" width="736">Individuals from the denominator with documented allergy status on record

</td></tr><tr style="mso-yfti-irow: 11; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Numerator Calculation

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736"><span style="mso-bidi-font-family: Calibri; mso-bidi-theme-font: minor-latin;"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';"> </span></span></span>Number of individuals from the denominator with documented allergy

</td></tr><tr style="mso-yfti-irow: 12; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Seguridad Measure Specification Process

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">[![image.png](https://docs.rxsafety.io/uploads/images/gallery/2023-08/scaled-1680-/bAOimage.png)](https://docs.rxsafety.io/uploads/images/gallery/2023-08/bAOimage.png)

<span style="mso-no-proof: yes;">  
</span>

</td></tr><tr style="mso-yfti-irow: 13; height: 30.1pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="154">Data Stratification

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 30.1pt;" valign="top" width="736">The measure rate will be reported as percent of patients within a single pharmacy.

If available and feasible, measure rate will be reported by type of pharmacy (e.g., health-system, community, specialty, mail-order, long-term care).

If available and feasible, measure rate will be reported by line of business (pharmacy Medicare rate, pharmacy Medicaid rate, pharmacy Commercial rate, and pharmacy uninsured rate).

Risk adjustment will be applied when available.

</td></tr><tr style="mso-yfti-irow: 14; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Value Sets

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">No value set is required for the calculation of this measure.

</td></tr><tr style="mso-yfti-irow: 15; height: 10.0pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="154">Future Iterations

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 10.0pt;" valign="top" width="736">Many pharmacy measures are designed as structure or process. Future goals of this concept include measures focused on updating the allergy status on an annual basis.

</td></tr><tr style="mso-yfti-irow: 16; mso-yfti-lastrow: yes; height: 19.55pt;"><td style="width: 115.55pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="154">Harmonization<sup>1</sup>

</td><td style="width: 551.7pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt; height: 19.55pt;" valign="top" width="736">Payors: N/A

Providers: N/A

</td></tr></tbody></table>

1\. Measures that have either the same target populations (denominator) or the same measure focus (numerators) may be considered related, whereas measures that have the same targeted population (denominator) and same measure focus (numerator), are considered competing measures. Measures being developed should be harmonized, where feasible, to previously established measures to decrease measure burden. Choose My Pharmacy measures are developed for pharmacy evaluation, which is a novel area for measurement science, no current measure evaluates this level of analysis. Choose My Pharmacy measures will be harmonized to the extent possible, recognizing different levels of analysis have different data elements, and instead the focus will be to vertically integrate the Choose My Pharmacy measures with other measurement systems and measures.